Effective March 2026, the Thai FDA introduced a major revision to its medical device change notification framework. The new guidance significantly expands the scope, classification, and documentation requirements for post-approval changes to medical devices in Thailand.
For companies marketing medical devices in Thailand, this update directly affects compliance risk, timelines, and operational planning.
Why This Matters
Medical devices evolve constantly — whether through design refinements, supplier changes, software updates, labeling revisions, or manufacturing improvements.
Under the 2026 guidance, more changes now require formal notification to the Thai FDA, and misclassification can result in:
- Delays in implementation
- Higher regulatory fees
- Rejection or requests for re-registration
Early regulatory assessment is now more critical than ever.
How Changes Are Classified
The Thai FDA now categorizes device changes into four main pathways:
- Major Change Notification (Class 2–4)
– Changes that may impact safety, performance, or clinical outcomes - Minor Change Notification (Class 2–4)
– Low-risk or administrative changes - Class 1 Change Notification
- Auto-Approval Changes (Class 1–4)
– Low-risk changes with faster turnaround
⚠︎ Certain changes — such as risk class upgrades or ungroupable new products — require a new registration rather than a change notification.
Key Change Areas Covered
The updated guidance applies to changes involving:
- Manufacturing sites, processes, or QMS
- Product design and specifications
- Software and cybersecurity
- Raw materials
- Labeling and Instructions for Use (IFU)
- Addition or removal of models, accessories, or product items
Each change type has distinct documentation and review expectations depending on whether it is major or minor.
Major vs. Minor: The Business Impact
Major Changes
- Higher regulatory fees
- More extensive documentation
- Possible external expert review
- Longer evaluation timelines
Minor Changes
- Simplified documentation
- Lower fees
- Thai FDA internal review only
- Faster processing
★ When multiple changes are submitted together, the highest-risk change determines the fee and timeline.
Executive Takeaway
The 2026 update represents a shift toward stricter post-market control in Thailand. Companies should:
- Review change management processes
- Align regulatory, QA, and R&D teams early
- Confirm notification requirements before implementing changes
Proactive compliance minimizes disruption and protects market access.
Want the full detailed guidance?
A comprehensive breakdown — covering all change scenarios, document requirements, and regulatory strategies — is available upon request.
▸✉ Click to email us to receive the complete reference.